Clinical trial Recruiting at 1 site Observational Ages 20 to 50 Women only

Current medical approaches for managing adenomyosis

Official title: Multicenter Observational Cohort Study on the Epidemiology of Therapeutic Strategies in Patients Affected by Adenomyosis

Run by San Carlo Public Hospital, Potenza, Italy · NCT07478614 · Data updated 2026-11-12

The study will see which treatments women aged 20–50 with adenomyosis receive and how long they continue them.

Quick facts

Study typeObservational
Ages20 Years to 50 Years
SexWomen only
Enrollment200 (estimated)
SponsorSan Carlo Public Hospital, Potenza, Italy
Academic / other
Locations1 site (Potenza)
StatusRecruiting
StartedJune 1, 2025
Main results expectedFebruary 18, 2026
Study endsFebruary 1, 2027
Registry record updatedMarch 17, 2026
Trial IDNCT07478614 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 20–50 with an imaging or histological diagnosis of adenomyosis who have significant pain (VAS ≥4) and/or heavy menstrual bleeding (PBAC >100), can provide informed consent, and can be followed at a participating center.

Probably not a fit

Women with current or prior endometriosis, suspected or confirmed pregnancy, those unable to provide informed consent, or asymptomatic women/outside the age range are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter observational cohort combining retrospective and prospective enrollment to document real-world therapeutic choices for adenomyosis. No treatments are assigned by the protocol; investigators record clinical, imaging, and treatment data and follow patients over time to capture treatment persistence. Inclusion requires imaging or histologic confirmation and significant symptoms (pain or heavy bleeding), while patients with endometriosis or pregnancy are excluded. Collected data will be analyzed to identify the criteria guiding treatment selection in routine clinical practice across centers.

Why it matters

Potential benefit: If successful, the study could clarify which commonly used treatments patients are most likely to continue and help guide clearer management recommendations for women with adenomyosis.

How similar studies have gone: Several observational cohorts have described patterns of care for adenomyosis, but randomized evidence and consensus on optimal treatment remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age between 20 and 50 years; Instrumental (ultrasound or MRI) and/or histological diagnosis of adenomyosis; Adenomyosis-associated pain with a VAS score ≥ 4 and/or presence of heavy menstrual bleeding (HMB) defined as a score \> 100 on the Pictorial Blood Assessment Chart (PBAC); Provision of written informed consent to participate in the study; Willingness to be followed at the participating center for the entire duration of the study.

Exclusion Criteria:

Current or previous clinical and/or instrumental diagnosis of endometriosis; Suspected or confirmed pregnancy; Inability to understand the purpose of the study and to provide informed consent.

Where it's running

  • Ospedale San Carlo
    Potenza, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.